Tuesday, April 12, 2022

< + > Remdesivir Resistance Reported Upon Treatment Of An Immunocompromised Patient

One of the questions that arises with any single drug treatment of an RNA virus is the level of resistance. Remdesivir has been approved as a stand-alone therapy for the treatment and prevention of COVID-19.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > ŌURA Welcomes Galen AI Team, Acquires Technology | IKS Health Announces Agreement to Acquire TruBridge

Check out today’s featured companies who have recently completed an M&A deal, and be sure to check out the full list of past healthcare ...